Search Results - "Villaron, Eva M"
-
1
Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease)
Published in Stem cell research & therapy (30-05-2018)“…Thromboangiitis obliterans (TAO), also known as Buerger's Disease, is an occlusive vasculitis linked with high morbidity and amputation risk. To date, TAO is…”
Get full text
Journal Article -
2
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II)
Published in Journal of translational medicine (26-08-2016)“…Mesenchymal stromal cells are a promising option to treat knee osteoarthritis. Their safety and usefulness must be confirmed and the optimal dose established…”
Get full text
Journal Article -
3
Autologous mesenchymal stem cell transplantation for spinal fusion: 10 years follow-up of a phase I/II clinical trial
Published in Stem cell research & therapy (11-04-2023)“…Posterolateral spinal fusion is the standard surgical approach for patients with degenerative disc disease. In our previously published article, we reported a…”
Get full text
Journal Article -
4
Autologous mesenchymal stromal cells embedded with Tissucol Duo ® for prevention of air leak after anatomical lung resection: results of a prospective phase I/II clinical trial with long-term follow-up
Published in Stem cell research & therapy (31-10-2023)“…Prolonged air leak (PAL) is the most frequent complication after pulmonary resection. Several measures have been described to prevent the occurrence of PAL in…”
Get full text
Journal Article -
5
Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up
Published in Stem cell research & therapy (22-02-2019)“…Posterolateral spinal fusion with autologous bone graft is considered the "gold standard" for lumbar degenerative disc disease (DDD) when surgical treatment is…”
Get full text
Journal Article -
6
Long-Term Results of a Phase I/II Clinical Trial of Autologous Mesenchymal Stem Cell Therapy for Femoral Head Osteonecrosis
Published in Journal of clinical medicine (08-03-2023)“…(1) Background: Osteonecrosis of the femoral head (ONFH) is characterized by impaired vascularization with ischemia resulting in bone cell death, leading to…”
Get full text
Journal Article -
7
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation
Published in Transfusion (Philadelphia, Pa.) (01-05-2012)“…BACKGROUND: Posttransplant cytopenias are a severe complication after allogeneic stem cell transplantation (allo‐SCT) and their origin is often multifactorial…”
Get full text
Journal Article -
8
Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation
Published in Experimental hematology (2006)Get full text
Journal Article -
9
Endothelial Progenitor Cells (EPC) with Colony Forming Capacity Are Derived from the Monocytic-Macrophage Lineage
Published in Blood (16-11-2005)“…The existence of circulating endothelial progenitor cells (EPC) in adult humans is under intensive investigation due to its potential clinical application. In…”
Get full text
Journal Article -
10
Comparison between Progenitor Cells from Mobilized Peripheral Blood (PB) in Healthy Donors and Non-Hodgkin's Lymphoma (NHL) Patients
Published in Blood (16-11-2004)“…INTRODUCTION: Peripheral blood stem cell (PBSC) mobilization is impaired in patients receiving chemotherapy but, as far as we know there is no data about the…”
Get full text
Journal Article -
11
Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation
Published in Transfusion (01-05-2012)Get full text
Report